{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:48:43Z","timestamp":1791611323733,"version":"4.3.4"},"reference-count":16,"publisher":"Japanese Urological Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2025,10,20]]},"DOI":"10.5980\/jpnjurol.116.106","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:13:14Z","timestamp":1791497594000},"page":"106-113","source":"Crossref","is-referenced-by-count":0,"title":["PROGNOSIS OF NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA","\u814e\u76c2\u5c3f\u7ba1\u764c\u306b\u5bfe\u3059\u308b\u814e\u5c3f\u7ba1\u5168\u6458\u9664\u8853\u5f8c\u306e\u4e88\u5f8c\u306e\u691c\u8a0e"],"prefix":"10.5980","volume":"116","author":[{"given":"Rieko","family":"Kimuro","sequence":"first","affiliation":[{"name":"Department of Urology, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Minato","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikko","family":"Tomisaki","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, University of Occupational and Environmental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Local Incorporated Administrative Agency Kurate Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD and Wood CG: Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer, 115, 1224-1233, 2009.","DOI":"10.1002\/cncr.24135"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Rink M, Sjoberg D, Comploj E, Margulis V, Xylinas E, Lee RK, Hansen J, Cha EK, Raman JD, Remzi M, Bensalah K, Novara G, Matin SF, Chun FK, Kikuchi E, Kassouf W, Martinez-Salamanca JI, Lotan Y, Seitz C, Pycha A, Zigeuner R, Karakiewicz PI, Scherr DS, Vickers AJ and Shariat SF: Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Ann Surg Oncol, 19, 4337-4344, 2013.","DOI":"10.1245\/s10434-012-2499-8"},{"key":"3","unstructured":"3) \u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7de8: \u814e\u76c2\u30fb\u5c3f\u7ba1\u764c\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32023\u5e74\u7248, \u7b2c1\u7248, p 93-94, \u533b\u5b66\u56f3\u66f8\u51fa\u7248, \u6771\u4eac, 2023."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O, Comp\u00e9rat EM, Dominguez-Escrig JL, G\u00fcrses Andersson I, Liedberg F, Mariappan P, Hugh Mostafid A, Pradere B, van Rhijn BWG, Shariat SF, Rai BP, Soria F, Soukup V, Wood RG, Xylinas EN, Masson-Lecomte A and Gontero P: European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur Urol, 84, 49-64, 2023.","DOI":"10.1016\/j.eururo.2023.03.013"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT, Harris C, Winterbottom A, Blacker A, Catto JWF, Chakraborti P, Donovan JL, Elliott PA, French A, Jagdev S, Jenkins B, Keeley FX Jr, Kockelbergh R, Powles T, Wagstaff J, Wilson C, Todd R, Lewis R and Hall E: Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet, 395, 1268-1277, 2020.","DOI":"10.1016\/S0140-6736(20)30415-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Ye D, Agerbaek M, Enting D, McDermott R, Gajate P, Peer A, Milowsky MI, Nosov A, Neif Antonio J Jr, Tupikowski K, Toms L, Fischer BS, Qureshi A, Collette S, Unsal-Kacmaz K, Broughton E, Zardavas D, Koon HB and Galsky MD: Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma. N Engl J Med, 384, 2102-2114, 2021.","DOI":"10.1056\/NEJMoa2034442"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kanda Y: Investigation of the freely available easy-to-use software  &apos;EZR&apos; for medical statistics. Bone Marrow Transplant, 48, 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P and Karakiewicz PI: Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer, 45, 3291-3297, 2009.","DOI":"10.1016\/j.ejca.2009.06.016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wheat JC, Weizer AZ, Wolf JS Jr, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fern\u00e1ndez M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ and Shariat SF: Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol, 30, 252-258, 2012.","DOI":"10.1016\/j.urolonc.2010.01.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Stangl-Kremser J, Muto G, Grosso AA, Briganti A, Comperat E, Di Maida F, Montironi R, Remzi M, Pradere B, Soria F, Albisinni S, Roupret M, Shariat SF, Minervini A, Teoh JY, Moschini M, Cimadamore A and Mari A: The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis. Urol Oncol, 40, 243-261, 2022.","DOI":"10.1016\/j.urolonc.2022.01.014"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Liu W, Sun L, Guan F, Wang F and Zhang G: Prognostic Value of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Systematic Review and Meta-Analysis. Dis Markers, 2019.","DOI":"10.1155\/2019\/7386140"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nakazawa H, Ito F and Tanabe K: Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol, 17, 848-854, 2010.","DOI":"10.1111\/j.1442-2042.2010.02610.x"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Sun M, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P and Karakiewicz PI: A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology, 75, 118-124, 2010.","DOI":"10.1016\/j.urology.2009.07.1296"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lee KS, Kim KH, Yoon YE, Choi KH, Yang SC and Han WK: Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy. Korean J Urol, 56, 41-47, 2015.","DOI":"10.4111\/kju.2015.56.1.41"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Liu W, Zhou Z, Dong D, Sun L and Zhang G: Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy. Yonsei Med J, 60, 174-181, 2019.","DOI":"10.3349\/ymj.2019.60.2.174"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H and Tanabe K: Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology, 69, 265-269, 2007.","DOI":"10.1016\/j.urology.2006.10.014"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/116\/4\/116_106\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:19Z","timestamp":1791608119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/116\/4\/116_106\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.116.106","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}